
- Specification
- Product Description:
- This protein protein interaction antibody pair set comes with two antibodies to detect the protein-protein interaction, one against the AKT1 protein, and the other against the CDKN1A protein for use in in situ Proximity Ligation Assay. See Publication Reference below.
- Reactivity:
- Human
- Quality Control Testing:
- Protein protein interaction immunofluorescence result.
Representative image of Proximity Ligation Assay of protein-protein interactions between AKT1 and CDKN1A. HeLa cells were stained with anti-AKT1 rabbit purified polyclonal antibody 1:1200 and anti-CDKN1A mouse monoclonal antibody 1:50. Each red dot represents the detection of protein-protein interaction complex. The images were analyzed using an optimized freeware (BlobFinder) download from The Centre for Image Analysis at Uppsala University.
- Supplied Product:
- Antibody pair set content: 1. AKT1 rabbit purified polyclonal antibody (100 ug) 2. CDKN1A mouse monoclonal antibody (40 ug) *Reagents are sufficient for at least 30-50 assays using recommended protocols.
- Storage Instruction:
- Store reagents of the antibody pair set at -20°C or lower. Please aliquot to avoid repeated freeze thaw cycle. Reagents should be returned to -20°C storage immediately after use.
- MSDS:
Download
- Datasheet:
Download
- Publication Reference
- 1.
- An analysis of protein-protein interactions in cross-talk pathways reveals CRKL as a novel prognostic marker in hepatocellular carcinoma.Liu CH, Chen TC, Chau GY, Jan YH, Chen CH, Hsu CN, Lin KT, Juang YL, Lu PJ, Cheng HC, Chen MH, Chang CF, Ting YS, Kao CY, Hsiao M, Huang CY. Mol Cell Proteomics. 2013 Feb 8. [Epub ahead of print]
- Applications
- In situ Proximity Ligation Assay (Cell)
- Application Image
- In situ Proximity Ligation Assay (Cell)
- AKT1
- CDKN1A
- Gene Information
- Entrez GeneID:
- 207
- Gene Name:
- AKT1
- Gene Alias:
- AKT,MGC99656,PKB,PKB-ALPHA,PRKBA,RAC,RAC-ALPHA
- Gene Description:
- v-akt murine thymoma viral oncogene homolog 1
- Omim ID:
- 164730, 181500
- Gene Ontology:
- Hyperlink
- Gene Summary:
- The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq
- Other Designations:
- RAC-alpha serine/threonine-protein kinase,murine thymoma viral (v-akt) oncogene homolog-1,protein kinase B,rac protein kinase alpha
- Gene Information
- Entrez GeneID:
- 1026
- Gene Name:
- CDKN1A
- Gene Alias:
- CAP20,CDKN1,CIP1,MDA-6,P21,SDI1,WAF1,p21CIP1
- Gene Description:
- cyclin-dependent kinase inhibitor 1A (p21, Cip1)
- Omim ID:
- 116899
- Gene Ontology:
- Hyperlink
- Gene Summary:
- This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen (PCNA), a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported. [provided by RefSeq
- Other Designations:
- CDK-interaction protein 1,DNA synthesis inhibitor,OTTHUMP00000016298,cyclin-dependent kinase inhibitor 1A,melanoma differentiation associated protein 6,wild-type p53-activated fragment 1
- Interactome 1
- Interactome 2
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>
经过无数次的大鼠肝脏插针灌注,忍受过实验结果不理想的打击和折磨,今天终于成功了,特分享些相关图片以鼓励还在奋战中的网友们。
我的步骤:
1、16-22天小鼠颈椎脱臼法处死后,75%酒精浸泡30秒消毒,睾丸取出后置预冷PBS,40分钟(路上所需时间)后开始处理。
2、剔除白膜,剪碎睾丸。0.25%胰酶(含edta)1.5ml/个睾丸37°C消化30-50分钟,等体积DMEM/F12含10%FBS终止消化,1000r/MIN离心5分钟,弃上液。
3、加0.1%胶原酶消化30分钟,过200目网筛,1000r/MIN离心5分钟,弃上液。
4、DMEM/F12含10%FBS5ml重悬后转如培养瓶,入孵育箱37°C5%CO2培养。
请教各位,我到底是哪里有问题,是胰酶消化的时间长了吗?
最近在做黄体化颗粒细胞分离培养,但是注射器吸取大卵泡液或者从下颗粒细胞离心时就会凝固成果冻状,大家有碰到过这样的事情么?已经好几次了,一直是这样,大家给支个招吧
近期根据经验总结了原代肿瘤细胞分离培养的2个关键因素。
1、组织的活性:如果我们取的都是坏死的组织或者结缔组织,我相信任何方法都不可能分离出来活的细胞的。另外,取完的组织要冷藏存放,并且越早分离越好,最好在24h内,最久不要超过48h。
2、组织的消化:在组织消化前,组织剪的越碎越好(1mm3左右为宜),组织的大小决定了组织的消化时间,不同组织消化时间差别较大:例如肺癌在2h-2.5h;食管癌在1个多小时。
希望可以帮到各位研友,另外如果大家有更好的经验可以一起来讨论!
各位师兄师姐:
我近期负责的课题,需要进行人类血液淋巴细胞和DC细胞的分离和培养,但我在方面懂的不多,想求助这方面的大神们。后续我需要做RT-qPCR,western-blot、免疫荧光等实验,我应该去多少ml全血比较好?全血怎么保存?怎么进行分离?后续怎么培养和保存?
谢谢!
请大神前辈指点指点,已经研三了,实验很不顺利,再这样都要延期的节奏了。请问最近急性分离出来的大鼠心肌细胞很不耐钙,做膜片钳封接不上可能是什么原因造成的?谢谢了!
大概步骤如下:c57小鼠大概六七只,酒精浸泡后不处死取出,迅速打开胸腔取出心脏放入冰PBS冲洗。待心脏取出完毕,冲洗移入有PBS青霉素小瓶中用眼科剪剪成较小组织块。
之后加入0.1%胰酶消化(之前浓度为0.25%,活细胞数量更少。)吹打1min.放入孵箱中3min.弃去上清,加入∥型胶原酶(0.1%)吹打10Min,放入孵箱15Min。取出后加入1ml胰酶。吹打1Min后加入含血清F12培养液终止消化,800转离心5Min。之后取沉淀重悬种板。90Min差速贴壁法纯化心肌细胞。
48h后只有少量(个位数)细胞贴壁,呈三角形。
第一次用0.25%胰酶时离心后有大量鼻涕样物质。
第二次胰酶浓度减小后没有,但细胞沉淀少,且为半透明微白。是不是离心时间不够。
感觉细胞整体状态都不好,几次都没有大量心肌细胞,更不用说观察到心肌细胞搏动。
老师们能不能帮忙分析一下是哪里的原因呢。
有没有比较稳定的小鼠乳鼠心肌细胞分离步骤呢。
希望大神快点出现。
前辈们好,近期老板布置任务需要分离小鼠肝脏细胞,查了好多文献,都没有写胶原酶的cat#,只写sigma订购,想请教下,是否有人做过,可以提供下货号和使用方法吗?十分感谢。另外,文中还提到digitonin,如果有一起用到的话麻烦帮我查看下,谢谢。
我做的临床试验,就想简单检测PBMC细胞的凋亡,上流式检测,有啥检测效果好的步骤推荐一下,谢谢

